Mixed Antagonist of Serotonin for Claudication Optimal Therapy
Condition(s):Intermittent ClaudicationLast Updated:December 19, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Intermittent ClaudicationLast Updated:December 19, 2008Completed
Condition(s):Blood Flow Speed; Coronary Flow VelocityLast Updated:February 13, 2012Completed
Condition(s):Multi Vessel Coronary Artery DiseaseLast Updated:December 22, 2021Unknown status
Condition(s):Stable Angina; Unstable Angina; STEMI; NSTEMI; Coronary DiseaseLast Updated:February 20, 2017Withdrawn
Condition(s):HealthyLast Updated:January 22, 2024Terminated
Condition(s):Coronary Artery DiseaseLast Updated:May 30, 2017Completed
Condition(s):Acute Coronary Syndrome; Atrial FibrillationLast Updated:July 14, 2023Recruiting
Condition(s):Acute Coronary SyndromesLast Updated:November 16, 2020Unknown status
Condition(s):Kawasaki Disease; Coronary Artery AneurysmLast Updated:January 19, 2024Not yet recruiting
Condition(s):Hibernation, Myocardial; Complete Occlusion of Coronary ArteryLast Updated:March 19, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.